The effect of The Morr herbal capsule and placebo on primary dysmenorrhea pai

Phase 3

Recruiting

• Conditions: Dysmenorrhea.; Primary dysmenorrhea; N94.4

• Registration Number: IRCT20200126046272N1
• Lead Sponsor: Booali Daroo pharmaceutical company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 146

Inclusion Criteria

Primary Dysmenorrhea
Ages 20 to 40 years

Exclusion Criteria

Having trouble coagulating, taking aspirin
Dysmenorrhea is very severe and unbearable
Pregnancy, lactation
Endometriosis
Laparotomy and Laparoscopy
Gastrointestinal inflammation and bleeding
Hyperthyroidism

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of dysmenorrhea. Timepoint: Baseline, one month after baseline, and baseline. Method of measurement: Based on Dysmenorrhea Pain Assessment Questionnaire.